The aV1ation Study
The Translational Medicine Program at the Center for Autism and the Developing Brain is recruiting individuals with autism from 5 to 17 years of age to participate in our study called aV1ation. The purpose of this study is to test an investigational medicine that blocks a hormone receptor in the brain linked to the control of socialization, stress, anxiety, and aggression. We want to see if this medicine is effective as a treatment to help improve social functioning in children with autism spectrum disorder (ASD). To determine this, participants will be randomly assigned to take the investigational drug or a placebo pill. Participation lasts up to 39 weeks and will involve regular visits to the Center for Autism and the Developing Brain. This will allow the study team to assess participants’ general health, social-communication skills, and social-interaction skills. Participants will not have to pay for any study-related treatments, lab tests, or assessments and will also be reimbursed $50 per visit.
If you would like more information or would like to participate in the research study, you can email Micah Davoren at [email protected] or call her at 914-997-5587.
See the study on RecruitMe.